Effect of substance P and its precursor α-protachykinin on intracellular free calcium concentration in human polymorphonuclear leukocytes

International Journal of Clinical and Laboratory Research

Volumn 26, Issue 2, 1996, Pages 106-111

  Nowak, D ^a   Hrabec, E ^a   Greger, J ^a   Piasecka, G ^a   Krol, M ^a   Bialasiewicz, P ^a   Antczak, A ^a   Plucienniczak, G ^b   Plucienniczak, A ^c  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Laboratory of Genetic Engineering   (Poland)

^c POLISH ACADEMY OF SCIENCES   (Poland)

Author keywords

Intracellular; Intracellular calcium stores; Polymorphonuclear leukocyte; Substance P; Protachykinin

Indexed keywords

SIGANUS;

EID: 0029759839     PISSN: 09405437     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02592352     Document Type: Article

References (30)

1. Marx J. How peptide hormones get ready for work. Science 1991; 252: 779.
2. Krause JE, Chirgwin JM, Carter MS, Xu ZS, Hershey AD. Three rat preprotachykinin mRNAs encode the neuro-peptides substance P and neurokinin A. Proc Natl Acad Sci USA 1987; 84 882.
3. Nyberg F, LeGreves P, Teremus L, Identification of substance P precursor forms in human brain tissue. Proc Natl Acad Sci USA 1985; 82: 3921.
4. Darby NJ, Smyth DG. Endopeptidases and prohormone processing. Biosci Rep 1990; 10: 1.
5. Andrews PC, Brayton K, Dixon IE. Precursors to regulatory peptides: their proteolytic processing. Experientia 1987; 43: 784
6. Hrabec E, Hrabec Z, Plucienniczak A. Biosynthesis of substance P and other mammalian neurokinins. Postepy Biochem 1992; 38: 23.
7. Hrabec E, Hrabec Z, Plucienniczak G, Skorupa G, Szczepanek A, Plucienniczak A, Uznanski B, Wilk A, Okruszek A, Koziolkiewicz M, Guga P, Stec WJ. Synthesis of a gene encoding bovine substance P precursors and its expression in Escherichia coli. Gene 1992; 117-259.
8. Brimijoin S, Lundberg J. Brodin E, Hokfelt T, Nilsson G. Axonal transport of substance P in the vagus nerve and sciatic nerves of the guinea pig. Brain Res 1980; 191: 443.
9. White MV, Kowalski ML, Kaliner MA. Mast cell secretagogues. In: Austin F, eds. Biochemistry of the acute allergic reactions: Fifth International Symposium. New York: Liss; 1989: 83-101
10. Foreman JC, Jordan CC. Neurogenic inflammation. Trends Pharmacol 1984; 3: 116.
11. Lembeck F, Holzer P. Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation. Naunyn-Schmiedebergs Arch Pharmacol 1979; 310: 175.
12. Sertl K, Wiederman C, Kowalski ML, Hurtado S, Plutchok J, Linnoila I, Pert CB, Kaliner MA, Substance P: the relationship between receptor distribution in rat lung and the capacity of substance P to stimulate vascular permeability. Am Rev Respir Dis 1988; 138: 151.
13. Stanisz AM, Befus D, Bienenstock J. Differential effects of vasoactive intestinal peptide, substance P. and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen. J Immunol 1986; 136: 152.
14. Kolasinski SL, Haines KA, Siegel EL, Cronstein BN, Abramson SB. Neuropeptides and inflammation. A somatostatin analog as a selective antagonists of neutrophil activation by substance P. Arthritis Rheum 1992; 35: 369.
15. Marasco VA, Showell HJ, Beker EL. Substance P binds to the formyl peptide chemotaxis receptor on the rabbit neutrophil. Biochem Biophys Res Commun 1981; 99: 1065.
16. Bar-Shavit Z, Goldman R, Stabinsky Y, Gottlieb P, Fridkin M, Teichberg VI. Blumberg S. Enhancement of phagocytosis - a newly found activity of substance P residing in its N-terminal tetrapeptide sequence. Biochem Biophys Res Commun 1980; 94: 1445.
17. 2+ concentration and inositol phosphate formation. J Immunol 1988; 141: 2118.
18. Hartung HP, Toyka KV. Activation of macrophages by substance P: induction of oxidative burst and thromboxane release. Eur J Pharmacol 1983; 89: 301.
19. Lloyds D, Hallett MB. Activation and priming of the human neutrophil oxidase response by substance P: distinct signal transduction pathways. Biochim Biophys Acta 1993; 1175: 207.
20. ++, and protein kinase C. J Bioenerg Biomembr 1988; 20: 709.
21. 2+ in human neutrophil responses to receptor agonist. Biochem J 1991; 278: 705.
22. Perez HD, Marder S, Elfman F, Ives HE. Human neutrophils contain subpopulations of specific granules exhibiting different sensitivities to changes in cytosolic free calcium. Biochem Biophys Res Commun 1987; 145: 976.
23. Marshall KW, Chiu B, Inman RD. Substance P and arthritis: analysis of plasma and synovial fluid levels. Arthritis Rheum 1990; 33: 87.
24. 2+ stores, and activates an influx pathway for divalent cations in HL-60 cells. J Biol Chem 1992; 267: 2318.
25. Boyüm A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 1968; 97 [Suppl]: 77.
26. Blue M, Janoff A. Possible mechanisms of emphysema in cigarette smokers. Release of elastase from human polymorphonuclear leukocytes by cigarette smoke condensate in vitro. Am Rev Respir Dis 1978; 117: 317.
27. 2+], transients in human polymorphonuclear leukocytes. J Lipid Mediator Cell Signal 1996; 13: 163.
28. Nowak D, Bialasiewicz P, Antczak A, Krol M, Piasecka G. Effect of cytochalasm B on intracellular free calcium concentration in human polymorphonuclear leukocytes after repeated stimulation with n-formyl-methionyl-leucyl-phenylalanine. Int J Clin Lab Res 1995; 25: 116.
29. Fabiato A, Fabiato F. Calculator programs for computing the composition of the solutions containing multiple metals and ligands used for experiments in skinned muscle cells. J Physiol (Paris) 1979; 75: 463.
30. Nowak D, Bialasiewicz P, Antczak A, Krol M, Piasecka G. Changes of intracellular free calcium concentration in human polymorphonuclear leukocytes after repeated stimulations with n-formyl-methionyl-leucyl-phenylalanine. Immunobiology 1995; 192-343